[144] Vistra Corp. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Vistra Corp. (VST) shows a proposed sale of 21,366 common shares through Fidelity Brokerage Services on the NYSE with an aggregate market value of $4,554,708.29. The filing lists the acquisition dates for the shares being sold as 09/18/2025 (from options originally granted 10/11/2016 and 04/09/2018) and indicates cash payment on 09/18/2025. The issuer has 338,820,324 shares outstanding, so the proposed sale represents a very small fraction of outstanding stock. The filing also discloses prior sales by James A. Burke totaling 148,121 shares between 09/10/2025 and 09/17/2025 with aggregated gross proceeds reported for each sale.

Insights

Securities Analyst

TL;DR: Insider selling disclosed but represents a negligible portion of shares outstanding; compliance documentation appears complete.

The Form 144 shows a proposed sale of 21,366 common shares valued at $4,554,708.29 and notes option-originated acquisitions dated 2016 and 2018 with cash payment on 09/18/2025. Recent reported sales by the same individual total 148,121 shares over a week, with gross proceeds listed per transaction. Relative to the issuer's 338,820,324 shares outstanding, these transactions are immaterial in size (well below 0.1%). From a market-impact perspective, the disclosed sales are unlikely to move the stock price. The filing satisfies Rule 144 disclosure elements: class, broker, amount, acquisition details, and recent sales history. No earnings or operational data are included, so assessment is limited to insider trading disclosure.

Corporate Governance Expert

TL;DR: The filing documents routine insider sales under Rule 144 and includes required representations about material nonpublic information.

This Form 144 identifies the seller, broker, quantity, aggregate market value, and acquisition history tied to option grants, and includes the seller's attestation regarding material adverse information. The listing of multiple recent sales by James A. Burke provides transparency on prior dispositions within the three-month lookback. There is no indication in this filing of atypical trading patterns, restrictive plan dates, or reliance on Rule 10b5-1; corresponding fields are blank. Governance-wise, the document appears procedurally compliant but does not provide context on reasons for sales, which is typical for Rule 144 notices.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	21366	4554708.29	338820324	09/18/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2025	Option Granted - 10/11/2016	Issuer			19200	09/18/2025	Cash
Common	09/18/2025	Option Granted - 04/09/2018	Issuer			2166	09/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/10/2025	19592	3933635.75
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/11/2025	43074	8991625.77
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/12/2025	21374	4335603.72
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/15/2025	21362	4481773.62
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/16/2025	21358	4565882.26
James A. Burke 6555 Sierra Drive Irving TX 75039	Common	09/17/2025	21361	4540506.03

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Vistra Corp. (VST) disclose?

The Form 144 discloses a proposed sale of 21,366 common shares valued at $4,554,708.29 through Fidelity on the NYSE and prior sales totaling 148,121 shares between 09/10/2025 and 09/17/2025.

Who is the seller named in the filing?

The recent sales listed in the filing were made by James A. Burke at the address provided; the proposed sale is filed through Fidelity Brokerage Services LLC.

How many shares of Vistra are outstanding and what fraction is being sold?

The filing reports 338,820,324 shares outstanding; the proposed sale of 21,366 shares represents a very small fraction of outstanding shares (significantly below 0.1%).

What is the acquisition source and payment method for the shares to be sold?

The shares were acquired via options (granted 10/11/2016 and 04/09/2018) and the filing indicates cash payment on 09/18/2025.

Are there recent insider sales disclosed in addition to the proposed sale?

Yes. The filing lists six prior sales by James A. Burke from 09/10/2025 through 09/17/2025 totaling 148,121 shares with gross proceeds reported for each transaction.